Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Blootstelling aan kinkhoest verbetert reactie op boostervaccin
dec 2022 | Bacteriële infecties, Vaccinatie